Companies Cutera
Cutera (CUTR): executive pay, fiscal 2023
Free brief. Every figure links to the company’s own filing.
Cutera no longer files a proxy statement; its last pay data is FY2023.
CEO vs. named peers69th pct.Of 17 peer CEOs
CEO pay, last three years
- $7,279,813FY2023
CEO total pay was $7,279,813 in fiscal 2023; the brief holds no earlier figure for this CEO.
FY2023: salary $271,023 · bonus $0 · stock awards $2,747,682 · option awards $4,250,008
Executives and directors
Daniel Plants · Executive ChairpersonJeffrey Jones · COORohan Seth · CFOMichael Karavitis · CTOSheila Hopkins · CEOStephana Patton · General CounselStuart Drummond · CFOTaylor Harris · CEODavid Mowry · CEOGregory A. Barrett · Former director (through FY2023)Janet D. Widmann · Former director (through FY2023)Jeryl L. Hilleman · Independent DirectorJoseph E. Whitters · Former director (through FY2023)Julian T. Park · Former director (through FY2023)Keith J. Sullivan · Independent DirectorKevin J. Cameron · Chair of the BoardNicholas S. Lewin · Independent DirectorTimothy J. O'Shea · Former director (through FY2023)
Frequently asked questions
Who was the highest-paid executive at Cutera in fiscal 2023?
As disclosed, Taylor Harris (Chief Executive Officer) was the highest-paid executive at Cutera in fiscal 2023, with total compensation of $7,279,813.
How does Cutera's chief executive pay compare to its disclosed peer group?
As disclosed, Taylor Harris's total compensation ranked at the 69th percentile of Cutera's disclosed peer group.
What is Cutera's CEO-to-median employee pay ratio?
As disclosed, Cutera's CEO-to-median employee pay ratio was 43:1.
How much does Cutera spend in total on board compensation for fiscal 2023?
As disclosed, Cutera reported total board compensation of $814,797 for fiscal 2023.
Answers are drawn only from the figures disclosed in this brief and cited to their location in the source filing. Where a figure required for an answer is not disclosed, that is stated rather than estimated.
Full detail
Every table from the filing. Open any section.
Summary compensation table
| Named executive officer | Salary | Bonus | Stock awards | Option awards | Non-equity incentive | Pension / NQDC | All other | Total |
|---|---|---|---|---|---|---|---|---|
| Taylor Harris | $271,023 | $0 | $2,747,682 | $4,250,008 | $0 | $0 | $11,100 | $7,279,813 |
| Chief Executive Officer | ||||||||
| David Mowry | 194,523 | — | 663,265 | 0 | 376,553 | 0 | 480,562 | 1,714,903 |
| Former Chief Executive Officer | ||||||||
| Sheila Hopkins | 225,402 | — | 696,366 | 74,996 | 225,402 | 0 | 54,125 | 1,276,291 |
| Former Interim Chief Executive Officer | ||||||||
| Michael Karavitis | 457,496 | 101,250 | 268,622 | 125,000 | 248,218 | 0 | 0 | 1,200,586 |
| Chief Technology Officer | ||||||||
| Stuart Drummond | 293,030 | — | 209,087 | 27,500 | 94,368 | 0 | 0 | 623,985 |
| Interim Chief Financial Officer | ||||||||
| Jeffrey Jones | 128,472 | — | 45,163 | 187,505 | 0 | 0 | 0 | 361,140 |
| Chief Operating Officer | ||||||||
| Rohan Seth | 158,438 | — | 0 | 0 | 191,097 | 0 | 0 | 349,535 |
| Former Chief Financial Officer | ||||||||
| Daniel Plants | 72,583 | — | 0 | 0 | 56,202 | 0 | 0 | 128,785 |
| Former Executive Chairperson | ||||||||
| Stephana Patton | 57,955 | — | 0 | 0 | 0 | 0 | 0 | 57,955 |
| Chief Legal Officer | ||||||||
A dash means the company reported no figure in that column; 0 means it reported zero. Figures are as printed in the filing, without adjustment.
Three-year trend — total compensation per named executive
| Named executive officer | FY2023 total | FY2022 total | FY2021 total | Δ FY2022→2023 |
|---|---|---|---|---|
| Taylor Harris | $7,279,813 | — | — | — |
| David Mowry | 1,714,903 | 2,597,522 | 4,065,626 | ↓ −882,619 |
| Sheila Hopkins | 1,276,291 | — | — | — |
| Michael Karavitis | 1,200,586 | 1,156,520 | 3,793,624 | ↑ +44,066 |
| Stuart Drummond | 623,985 | — | — | — |
| Jeffrey Jones | 361,140 | — | — | — |
| Rohan Seth | 349,535 | 953,346 | 2,253,315 | ↓ −603,811 |
| Daniel Plants | 128,785 | 788,275 | 1,021,204 | ↓ −659,490 |
| Stephana Patton | 57,955 | — | — | — |
Prior-year totals as disclosed in the corresponding proxy; deltas are computed values with the derivation shown in the register.
Incentive-plan design — the Compensation Discussion & Analysis
The Compensation Committee strikes a balance between fixed base pay and pay-for-performance programs that tie compensation directly to specific business goals and management objectives. The program is designed to support near-term financial and strategic objectives, promote long-term growth, and align the interests of executive officers with those of stockholders through competitive base salaries and equity-based incentives.
| CEO STI target (% of salary) | 100% |
|---|---|
| CEO LTI target (% of salary) | — |
| Independent consultant | Compensia |
| Clawback policy | true |
| Anti-hedging | true |
| Anti-pledging | false |
Equity grants and outstanding awards
Grants of plan-based awards — fiscal year 2023
| Executive | Award | Grant date | Threshold | Target | Granted | Maximum | Grant-date fair value |
|---|---|---|---|---|---|---|---|
| Sheila Hopkins | OPTION | 2023-04-27 | — | — | 17,085 | — | $375,015 |
| Sheila Hopkins | OPTION | 2023-08-01 | — | — | 6,368 | — | 125,004 |
| Stuart Drummond | OPTION | 2023-04-15 | — | — | 6,687 | — | 149,989 |
| Stuart Drummond | OPTION | 2023-04-12 | — | — | 1,013 | — | 59,098 |
| Michael Karavitis | OPTION | 2023-04-12 | — | — | — | — | 179,081 |
| Sheila Hopkins | OPTION | 2023-07-14 | — | — | 7,770 | — | 74,996 |
| Taylor Harris | OPTION | 2023-08-18 | — | — | 249,336 | — | 2,747,682 |
| Stuart Drummond | OPTION | 2023-04-12 | — | — | 2,519 | — | 27,500 |
| Michael Karavitis | OPTION | 2023-04-12 | — | — | 4,606 | — | 89,541 |
| David Mowry | OPTION | 2023-05-11 | — | — | 40,241 | — | 569,008 |
| Michael Karavitis | OPTION | 2023-04-12 | — | — | 11,450 | — | 125,000 |
| Taylor Harris | OPTION | 2023-08-18 | — | — | 735,295 | — | 4,000,005 |
| Jeffrey Jones | OPTION | 2023-11-07 | — | — | 31,256 | — | 187,505 |
| Jeffrey Jones | OPTION | 2023-11-07 | — | — | 12,306 | — | 45,163 |
| Sheila Hopkins | OPTION | 2023-07-03 | — | — | 8,170 | — | 125,001 |
| Taylor Harris | OPTION | 2023-05-19 | — | — | 25,327 | — | 250,003 |
| Sheila Hopkins | OPTION | 2023-07-14 | — | — | 4,507 | — | 71,346 |
| David Mowry | OPTION | 2023-05-11 | — | — | — | — | 94,257 |
Vehicle mix — grant-date fair value by award type
| Named executive officer | Time-vested (RSU) | Performance-vested (PSU) | Options / SARs | % performance-vested |
|---|---|---|---|---|
| Sheila Hopkins | $0 | $0 | $771,362 | 0.0% |
| Stuart Drummond | 0 | 0 | 236,587 | 0.0% |
| Michael Karavitis | 0 | 0 | 393,622 | 0.0% |
| Taylor Harris | 0 | 0 | 6,997,690 | 0.0% |
| David Mowry | 0 | 0 | 663,265 | 0.0% |
| Jeffrey Jones | 0 | 0 | 232,668 | 0.0% |
% performance-vested = PSU grant-date fair value ÷ (RSU + PSU + Options), a computed value with the derivation shown in the register.
Outstanding equity awards at fiscal year-end 2023
| Executive | Award | Shares unvested | Exercise price | Market value unvested |
|---|---|---|---|---|
| Stuart Drummond | RSU | 203 | — | $716 |
| Stuart Drummond | RSU | 577 | — | 2,035 |
| Stuart Drummond | RSU | 710 | — | 2,506 |
| Michael Karavitis | RSU | 921 | — | 3,252 |
| Stuart Drummond | RSU | 1,013 | — | 3,576 |
| Michael Karavitis | RSU | 1,310 | — | 4,624 |
| Stuart Drummond | Option | 1,535 | 33.45 | — |
| Michael Karavitis | RSU | 1,729 | — | 6,103 |
| Michael Karavitis | RSU | 1,832 | — | 6,467 |
| Stuart Drummond | RSU | 1,874 | — | 6,615 |
| Michael Karavitis | Option | 2,031 | 32.87 | — |
| Michael Karavitis | RSU | 2,131 | — | 7,522 |
| Stuart Drummond | Option | 2,519 | 19.44 | — |
| Sheila Hopkins | RSU | 2,737 | — | 9,662 |
| David Mowry | Option | 3,420 | 32.87 | — |
| Sheila Hopkins | RSU | 4,507 | — | 15,910 |
| Michael Karavitis | RSU | 4,606 | — | 16,259 |
| Michael Karavitis | Option | 4,608 | 33.45 | — |
| Sheila Hopkins | RSU | 6,368 | — | 22,479 |
| Stuart Drummond | RSU | 6,687 | — | 23,605 |
| Sheila Hopkins | Option | 7,770 | 15.83 | — |
| Sheila Hopkins | RSU | 8,170 | — | 28,840 |
| Michael Karavitis | Option | 11,450 | 19.44 | — |
| Jeffrey Jones | RSU | 12,306 | — | 43,440 |
| Sheila Hopkins | RSU | 17,085 | — | 60,310 |
| David Mowry | Option | 24,580 | 33.45 | — |
| Taylor Harris | Option | 25,327 | 16.84 | — |
| Jeffrey Jones | Option | 31,256 | 3.67 | — |
| Taylor Harris | RSU | 249,336 | — | 880,156 |
| Taylor Harris | Option | 735,295 | 11.02 | — |
Director compensation
| Director | Cash fees | Stock awards | Option awards | Non-equity incentive | All other | Total |
|---|---|---|---|---|---|---|
| Kevin J. CameronIndependent · Board Chair · Audit Committee · Governance and Corporate Responsibility Committee (Chair) | $35,397 | $0 | $250,003 | — | $0 | $285,400 |
| Nicholas S. LewinIndependent · Audit Committee · Compensation Committee (Chair) · Governance and Corporate Responsibility Committee | 18,784 | 0 | 250,003 | — | 0 | 268,787 |
| Julian T. ParkIndependent · Not standing for re-election · Departed during FY | 100,250 | 142,707 | 0 | — | 0 | 242,957 |
| Janet D. WidmannIndependent · Compensation Committee · Not standing for re-election · Departed during FY | 91,989 | 0 | 149,992 | — | 0 | 241,981 |
| Keith J. SullivanIndependent · Audit Committee (Chair) · Compensation Committee | 19,750 | 200,295 | 0 | — | 0 | 220,045 |
| Gregory A. BarrettIndependent · Compensation Committee · Not standing for re-election · Departed during FY | 97,500 | 0 | 0 | — | 0 | 97,500 |
| Timothy J. O'SheaIndependent · Not standing for re-election · Departed during FY | 65,625 | 0 | 0 | — | 0 | 65,625 |
| Joseph E. WhittersIndependent · Not standing for re-election · Departed during FY | 42,500 | 0 | 0 | — | 0 | 42,500 |
| Taylor C. HarrisEmployee director | 0 | 0 | 0 | — | 0 | 0 |
| Sheila A. HopkinsIndependent · Compensation Committee · Governance and Corporate Responsibility Committee · Not standing for re-election · Departed during FY | 0 | 0 | 0 | — | 0 | 0 |
| Jeryl L. HillemanIndependent · Governance · Compensation · Audit · Newly elected | 0 | 0 | 0 | — | 0 | 0 |
Board fee structure and ownership guideline
| Annual cash retainer | $60,000 |
|---|---|
| Annual equity retainer | $150,000 |
| Per board meeting fee | — |
| Committee chair fees (audit / comp / nom-gov) | 25,000 / 20,000 / 10,000 |
| Stock ownership guideline | As of March 31, 2023, the non-employee directors’ holdings and target guidelines were as follows: ... Minimum Stock Ownership Required ... 5,200 |
Total cost of the board
| Component | FY2023 |
|---|---|
| Cash retainers and fees | $471,795 |
| Equity awards (grant-date value) | $343,002 |
| All other compensation | $0 |
| Total cost of the board | $814,797 |
Computed as the sum of the director compensation table rows above; inputs and formula shown in the register.
Peer group, and who names Cutera as a peer
Companies that benchmark against CUTR
8 companies name CUTR as a compensation peer
- ACCURAY INCARAYFY2026
- ANGIODYNAMICS INCANGOFY2026
- ESTABLISHMENT LABS HOLDINGS INC.ESTAFY2025
- SURMODICS INCSRDXFY2024
- SURMODICS INCSRMDFY2024
- TACTILE SYSTEMS TECHNOLOGY INCTCMDFY2025
- ZYNEX INCZYNXFY2024
- ZYNEX INCZYXIFY2024
Each company listed discloses CUTR in its own benchmarking peer group, as disclosed in each company's most recent proxy statement within the last two proxy seasons. Two companies are therefore absent by design: one that named CUTR in an earlier year and no longer does, and one whose own most recent disclosure is older than the last two seasons.
Disclosed peer group — fiscal year 2023
The compensation peer group as the company disclosed it in its own proxy — the reference set behind the percentile above.
ANGO AngioDynamicsZYXI ZynexARAY AccurayAIRS AirSculpt TechnologiesRVNC Revance TherapeuticsEOLS EvolusESTA Establishment Labs HoldingsAORT ArtivionCERS CerusSKIN The Beauty Health CompanySILK Silk Road MedicalANIK Anika TherapeuticsBVS Bioventus NanoString TechnologiesAXGN AxoGenTCMD Tactile Systems TechnologyNVRO Nevro
Peer reciprocity
The companies Cutera names as compensation peers that name it back in their own disclosed peer groups.
AngioDynamics (ANGO)66Zynex (ZYXI)67Accuray (ARAY)68Establishment Labs Holdings (ESTA)69Tactile Systems Technology (TCMD)70
Chief executive pay against the peer group
Most recent fiscal-year chief executive compensation at each disclosed peer, taken from that company’s own proxy statement.
| Rank | Company | FY | Chief executive | Salary | Stock awards | Option awards | Non-equity incentive | Total |
|---|---|---|---|---|---|---|---|---|
| 1 | Silk Road Medical | 2023 | Chas McKhann | $105,871 | $13,123,059 | $0 | $93,275 | $13,423,834 |
| 2 | Nevro | 2023 | Kevin Thornal | 515,625 | 10,080,173 | 0 | 402,750 | 11,453,548 |
| 3 | Revance Therapeutics | 2023 | Mark Foley | 720,000 | 8,810,731 | 0 | 522,720 | 10,068,915 |
| 4 | AxoGen | 2025 | Michael Dale | 775,865 | 7,342,895 | 0 | 906,133 | 9,047,454 |
| 5 | The Beauty Health Company | 2025 | Marla Beck | 796,154 | 3,713,635 | 0 | 1,050,000 | 7,662,185 |
| 6 | Cutera | 2023 | Taylor Harris | 271,023 | 2,747,682 | 4,250,008 | 0 | 7,279,813 |
| 7 | Artivion | 2025 | J. Patrick Mackin | 835,145 | 5,006,990 | 0 | 991,368 | 6,883,108 |
| 8 | Evolus | 2025 | David Moatazedi | 775,000 | 3,886,569 | 1,296,697 | 429,000 | 6,412,214 |
| 9 | AngioDynamics | 2026 | James Clemmer | 828,171 | 3,689,866 | 0 | 1,502,491 | 6,060,145 |
| 10 | Accuray | 2026 | Steve La Neve | 525,000 | 4,263,749 | 0 | 0 | 5,114,466 |
| 11 | AirSculpt Technologies | 2025 | Yogesh Jashnani | 660,513 | 3,917,591 | 0 | 140,000 | 4,980,604 |
| 12 | Bioventus | 2025 | Robert Claypoole | 824,110 | 1,982,530 | 662,949 | 781,256 | 4,299,108 |
| 13 | Cerus | 2025 | William Greenman | 793,750 | 2,242,585 | 0 | 756,000 | 3,794,657 |
| 14 | Tactile Systems Technology | 2025 | Sheri Dodd | 675,000 | 2,019,978 | 0 | 737,438 | 3,466,916 |
| 15 | Establishment Labs Holdings | 2025 | Filippo Caldini | 528,750 | 849,953 | 851,547 | 622,800 | 2,882,033 |
| 16 | Anika Therapeutics | 2025 | Stephen Griffin | 500,000 | 1,215,222 | 0 | 0 | 2,033,370 |
| 17 | Zynex | 2024 | Thomas Sandgaard | 700,000 | 112,458 | 0 | 170,625 | 991,810 |
Each peer’s compensation is from its most recently filed proxy; fiscal years differ by company. Each peer’s figures come from its own filings; the subject company is highlighted. Peers whose chief executive compensation is outside our coverage universe are stated as such, never left blank.
Incentive design against the same peers
| Company | Annual incentive payout | Long-term vehicle mix | PSU measures include TSR | Compensation consultant |
|---|---|---|---|---|
| Cutera | not disclosed | not disclosed | No | Compensia |
| Accuray | 0% | PSU 50 · RSU 50 | No | Exequity LLP |
| AirSculpt Technologies | 0% for revenue/EBITDA targets. 100% of the 20% target (i.e., $140,000) for Mr. Jashnani for debt prepayment.% | RSUs 50 · PSUs 50 | Yes — Relative Total Shareholder Return (rTSR) | Haigh & Co. |
| AngioDynamics | 180% | PSU 50 · RSU 50 | No | Meridian Compensation Partners, LLC |
| Anika Therapeutics | 100% | PSU 67 · RSU 33 | No | Willis Towers Watson |
| Artivion | 118.7% | PSU 50 · RSU 50 | No | Willis Towers Watson |
| AxoGen | 116.79% | PSU 50 · RSU 50 | No | Aon |
| Bioventus | not disclosed | RSU 49 · PSU 26 · Options 25 | No | Aon plc |
| Cerus | 126% | not disclosed | No | Alpine |
| Establishment Labs Holdings | 103.8% | RSU 50 · Options 50 | not disclosed | Alpine Rewards LLC |
| Evolus | 55% | not disclosed | No | Radford, an Aon Company |
| Nevro | 53.7% | not disclosed | No | Aon |
| Revance Therapeutics | 96.8% | PSU 100 | No | FW Cook |
| Silk Road Medical | not disclosed | PSU 50 · RSU 50 | Yes — Total Stockholder Return (TSR) relative to peer group | Compensia, Inc. |
| Tactile Systems Technology | 115% | PSU 50 · RSU 50 | No | Aon Consulting, Inc. |
| The Beauty Health Company | 140% | RSU 75 · PSU 25 | Yes — Relative TSR | Frederic W. Cook & Co. (FW Cook) |
| Zynex | not disclosed | not disclosed | not disclosed | not disclosed |
Read from each company’s Compensation Discussion and Analysis: annual incentive payout as a percentage of target, the disclosed long-term vehicle mix, whether performance-share measures include a total shareholder return component, and the retained compensation consultant. “Not disclosed” appears only where the company’s filing does not state the item.
Say-on-pay history and pay ratio
No say-on-pay vote is on file for this company.
CEO pay ratio
| Ratio (CEO : median employee) | 43 : 1 |
|---|---|
| CEO total compensation | $4,065,626 |
| Median employee compensation | $94,766 |
Insider trades since the proxy
Every insider equity transaction reported on Form 4 after the 2023 proxy statement — acquisitions, dispositions, exercises, and withholdings — and therefore not reflected in any table in that document.
| Insider | Role | Transaction date | Code | Shares | Price | Value | Security | Source |
|---|---|---|---|---|---|---|---|---|
| Stuart Drummond | Interim CFO | 2025-01-01 | A | 101 | $0 | $39 | Common | Form 4 ↗ |
| Stuart Drummond | Interim CFO | 2025-01-01 | D | 22 | 0 | 9 | Common | Form 4 ↗ |
| Stuart Drummond | Interim CFO | 2025-01-01 | D | 47 | 0 | 18 | Common | Form 4 ↗ |
| Stuart Drummond | Interim CFO | 2025-02-01 | D | 22 | 0 | 9 | Common | Form 4 ↗ |
| Taylor C. Harris | Director | 2025-02-07 | D | 4,620 | 0 | 2,027 | Common | Form 4 ↗ |
| Stephana Patton | Chief Legal Officer | 2025-02-13 | D | 623 | 0 | 261 | Common | Form 4 ↗ |
Transaction codes per Form 4: A acquisition · S open-market sale · F tax withholding · M option exercise · G gift. Value = shares × price as reported. Dividend-equivalent and fractional-share accrual rows (derivative Class A, under $10,000 and under 2,000 shares) are aggregated per date; every row appears in full below.
Sources (70 citations)
Each figure is listed with the filing it comes from, where it appears in that filing, and the value as printed. Any figure can be independently confirmed against the source.
- Section 01, Taylor Harris. DEF 14A, filed 2024-06-17. Section “2023 Summary Compensation Table” · page 58. As printed: 7,279,813. View filing ↗
- Section 01, David Mowry. DEF 14A, filed 2024-06-17. Section “2023 Summary Compensation Table” · page 58. As printed: 1,714,903. View filing ↗
- Section 01, Sheila Hopkins. DEF 14A, filed 2024-06-17. Section “2023 Summary Compensation Table” · page 58. As printed: 1,276,291. View filing ↗
- Section 01, Michael Karavitis. DEF 14A, filed 2024-06-17. Section “2023 Summary Compensation Table” · page 58. As printed: 1,200,586. View filing ↗
- Section 01, Stuart Drummond. DEF 14A, filed 2024-06-17. Section “2023 Summary Compensation Table” · page 58. As printed: 623,985. View filing ↗
- Section 01, Jeffrey Jones. DEF 14A, filed 2024-06-17. Section “2023 Summary Compensation Table” · page 58. As printed: 361,140. View filing ↗
- Section 01, Rohan Seth. DEF 14A, filed 2024-06-17. Section “2023 Summary Compensation Table” · page 58. As printed: 349,535. View filing ↗
- Section 01, Daniel Plants. DEF 14A, filed 2024-06-17. Section “2023 Summary Compensation Table” · page 58. As printed: 128,785. View filing ↗
- Section 01, Stephana Patton. DEF 14A, filed 2024-06-17. Section “2023 Summary Compensation Table” · page 58. As printed: 57,955. View filing ↗
- Section 03, Sheila Hopkins OPTION. DEF 14A, filed 2024-06-17. Section “2023 Grants of Plan-Based Awards Table” · grants of plan-based awards table. View filing ↗
- Section 03, Sheila Hopkins OPTION. DEF 14A, filed 2024-06-17. Section “2023 Grants of Plan-Based Awards Table” · grants of plan-based awards table. View filing ↗
- Section 03, Stuart Drummond OPTION. DEF 14A, filed 2024-06-17. Section “2023 Grants of Plan-Based Awards Table” · grants of plan-based awards table. View filing ↗
- Section 03, Stuart Drummond OPTION. DEF 14A, filed 2024-06-17. Section “2023 Grants of Plan-Based Awards Table” · grants of plan-based awards table. View filing ↗
- Section 03, Michael Karavitis OPTION. DEF 14A, filed 2024-06-17. Section “2023 Grants of Plan-Based Awards Table” · grants of plan-based awards table. View filing ↗
- Section 03, Sheila Hopkins OPTION. DEF 14A, filed 2024-06-17. Section “2023 Grants of Plan-Based Awards Table” · grants of plan-based awards table. View filing ↗
- Section 03, Taylor Harris OPTION. DEF 14A, filed 2024-06-17. Section “2023 Grants of Plan-Based Awards Table” · grants of plan-based awards table. View filing ↗
- Section 03, Stuart Drummond OPTION. DEF 14A, filed 2024-06-17. Section “2023 Grants of Plan-Based Awards Table” · grants of plan-based awards table. View filing ↗
- Section 03, Michael Karavitis OPTION. DEF 14A, filed 2024-06-17. Section “2023 Grants of Plan-Based Awards Table” · grants of plan-based awards table. View filing ↗
- Section 03, David Mowry OPTION. DEF 14A, filed 2024-06-17. Section “2023 Grants of Plan-Based Awards Table” · grants of plan-based awards table. View filing ↗
- Section 03, Michael Karavitis OPTION. DEF 14A, filed 2024-06-17. Section “2023 Grants of Plan-Based Awards Table” · grants of plan-based awards table. View filing ↗
- Section 03, Taylor Harris OPTION. DEF 14A, filed 2024-06-17. Section “2023 Grants of Plan-Based Awards Table” · grants of plan-based awards table. View filing ↗
- Section 03, Jeffrey Jones OPTION. DEF 14A, filed 2024-06-17. Section “2023 Grants of Plan-Based Awards Table” · grants of plan-based awards table. View filing ↗
- Section 03, Jeffrey Jones OPTION. DEF 14A, filed 2024-06-17. Section “2023 Grants of Plan-Based Awards Table” · grants of plan-based awards table. View filing ↗
- Section 03, Sheila Hopkins OPTION. DEF 14A, filed 2024-06-17. Section “2023 Grants of Plan-Based Awards Table” · grants of plan-based awards table. View filing ↗
- Section 03, Taylor Harris OPTION. DEF 14A, filed 2024-06-17. Section “2023 Grants of Plan-Based Awards Table” · grants of plan-based awards table. View filing ↗
- Section 03, Sheila Hopkins OPTION. DEF 14A, filed 2024-06-17. Section “2023 Grants of Plan-Based Awards Table” · grants of plan-based awards table. View filing ↗
- Section 03, David Mowry OPTION. DEF 14A, filed 2024-06-17. Section “2023 Grants of Plan-Based Awards Table” · grants of plan-based awards table. View filing ↗
- Section 07, pay ratio. DEF 14A, filed 2022-05-02. Section “CEO Pay Ratio”. As printed: 43 : 1. View filing ↗
- Section 08, Kevin J. Cameron. DEF 14A, filed 2024-06-17. Section “Director Compensation”. As printed: 285,400. View filing ↗
- Section 08, Nicholas S. Lewin. DEF 14A, filed 2024-06-17. Section “Director Compensation”. As printed: 268,787. View filing ↗
- Section 08, Julian T. Park. DEF 14A, filed 2024-06-17. Section “Director Compensation”. As printed: 242,957. View filing ↗
- Section 08, Janet D. Widmann. DEF 14A, filed 2024-06-17. Section “Director Compensation”. As printed: 241,981. View filing ↗
- Section 08, Keith J. Sullivan. DEF 14A, filed 2024-06-17. Section “Director Compensation”. As printed: 220,045. View filing ↗
- Section 08, Gregory A. Barrett. DEF 14A, filed 2024-06-17. Section “Director Compensation”. As printed: 97,500. View filing ↗
- Section 08, Timothy J. O'Shea. DEF 14A, filed 2024-06-17. Section “Director Compensation”. As printed: 65,625. View filing ↗
- Section 08, Joseph E. Whitters. DEF 14A, filed 2024-06-17. Section “Director Compensation”. As printed: 42,500. View filing ↗
- Section 08, Taylor C. Harris. DEF 14A, filed 2024-06-17. Section “Director Compensation”. As printed: 0. View filing ↗
- Section 08, Sheila A. Hopkins. DEF 14A, filed 2024-06-17. Section “Director Compensation”. As printed: 0. View filing ↗
- Section 08, Jeryl L. Hilleman. DEF 14A, filed 2024-06-17. Section “Director Compensation”. As printed: 0. View filing ↗
- Section 02, Stuart Drummond 2025-01-01. Form 4, filed 2025-01-03. Insider equity transaction reported since the proxy statement. View filing ↗
- Section 02, Stuart Drummond 2025-01-01. Form 4, filed 2025-01-03. Insider equity transaction reported since the proxy statement. View filing ↗
- Section 02, Stuart Drummond 2025-01-01. Form 4, filed 2025-01-03. Insider equity transaction reported since the proxy statement. View filing ↗
- Section 02, Stuart Drummond 2025-02-01. Form 4, filed 2025-02-04. Insider equity transaction reported since the proxy statement. View filing ↗
- Section 02, Taylor C. Harris 2025-02-07. Form 4, filed 2025-02-21. Insider equity transaction reported since the proxy statement. View filing ↗
- Section 02, Stephana Patton 2025-02-13. Form 4, filed 2025-02-21. Insider equity transaction reported since the proxy statement. View filing ↗
- Section 01 trend, Δ column (computed). Computed. Δ = current-FY total − prior-FY total per named officer.
- Section 03b vehicle mix (computed). Computed. RSU / PSU / Options grant-date fair values summed per officer from the grants table; % performance-vested = PSU ÷ (RSU+PSU+Options).
- Section 09b board cost (computed). Computed. Cash 471,795 + equity 343,002 + all other 0 = 814,797, summed across the director compensation table rows.
- Silk Road Medical, Section 10b CEO total. DEF 14A, filed 2024-04-26. CEO total compensation as printed in Silk Road Medical's own proxy. As printed: 13,423,834. View filing ↗
- Nevro, Section 10b CEO total. DEF 14A, filed 2024-04-12. CEO total compensation as printed in Nevro's own proxy. As printed: 11,453,548. View filing ↗
- Revance Therapeutics, Section 10b CEO total. DEF 14A, filed 2024-03-21. CEO total compensation as printed in Revance Therapeutics's own proxy. As printed: 10,068,915. View filing ↗
- AxoGen, Section 10b CEO total. DEF 14A, filed 2026-04-29. CEO total compensation as printed in AxoGen's own proxy. As printed: 9,047,454. View filing ↗
- The Beauty Health Company, Section 10b CEO total. DEF 14A, filed 2026-04-24. CEO total compensation as printed in The Beauty Health Company's own proxy. As printed: 7,662,185. View filing ↗
- Cutera (subject), Section 10b CEO total. DEF 14A, filed 2024-06-17. CEO total compensation as printed in Cutera's own proxy. As printed: 7,279,813. View filing ↗
- Artivion, Section 10b CEO total. DEF 14A, filed 2026-04-01. CEO total compensation as printed in Artivion's own proxy. As printed: 6,883,108. View filing ↗
- Evolus, Section 10b CEO total. DEF 14A, filed 2026-04-29. CEO total compensation as printed in Evolus's own proxy. As printed: 6,412,214. View filing ↗
- AngioDynamics, Section 10b CEO total. DEF 14A, filed 2026-10-08. CEO total compensation as printed in AngioDynamics's own proxy. As printed: 6,060,145. View filing ↗
- Accuray, Section 10b CEO total. DEF 14A, filed 2026-10-16. CEO total compensation as printed in Accuray's own proxy. As printed: 5,114,466. View filing ↗
- AirSculpt Technologies, Section 10b CEO total. DEF 14A, filed 2026-04-15. CEO total compensation as printed in AirSculpt Technologies's own proxy. As printed: 4,980,604. View filing ↗
- Bioventus, Section 10b CEO total. DEF 14A, filed 2026-04-22. CEO total compensation as printed in Bioventus's own proxy. As printed: 4,299,108. View filing ↗
- Cerus, Section 10b CEO total. DEF 14A, filed 2026-04-22. CEO total compensation as printed in Cerus's own proxy. As printed: 3,794,657. View filing ↗
- Tactile Systems Technology, Section 10b CEO total. DEF 14A, filed 2026-03-25. CEO total compensation as printed in Tactile Systems Technology's own proxy. As printed: 3,466,916. View filing ↗
- Establishment Labs Holdings, Section 10b CEO total. DEF 14A, filed 2026-04-10. CEO total compensation as printed in Establishment Labs Holdings's own proxy. As printed: 2,882,033. View filing ↗
- Anika Therapeutics, Section 10b CEO total. DEF 14A, filed 2026-04-28. CEO total compensation as printed in Anika Therapeutics's own proxy. As printed: 2,033,370. View filing ↗
- Zynex, Section 10b CEO total. DEF 14A, filed 2025-03-28. CEO total compensation as printed in Zynex's own proxy. As printed: 991,810. View filing ↗
- Section 10a, AngioDynamics reciprocity. DEF 14A. AngioDynamics names Cutera in its own disclosed peer group (read from its most recent proxy). View filing ↗
- Section 10a, Zynex reciprocity. DEF 14A. Zynex names Cutera in its own disclosed peer group (read from its most recent proxy). View filing ↗
- Section 10a, Accuray reciprocity. DEF 14A. Accuray names Cutera in its own disclosed peer group (read from its most recent proxy). View filing ↗
- Section 10a, Establishment Labs Holdings reciprocity. DEF 14A. Establishment Labs Holdings names Cutera in its own disclosed peer group (read from its most recent proxy). View filing ↗
- Section 10a, Tactile Systems Technology reciprocity. DEF 14A. Tactile Systems Technology names Cutera in its own disclosed peer group (read from its most recent proxy). View filing ↗